IMA peer analysis
ImageneBio (IMA) against its competitors: price, today's move, 1-year return and market value side by side.
- IMA's peers: ARTV (Artiva Biotherapeutics), CNTB (Connect Biopharma), CNTX (Context Therapeutics), IFRX (InflaRx), KLRS (Kalaris Therapeutics), MGX (Metagenomi Therapeutics), OVID (Ovid Therapeutics), STRO (Sutro Biopharma).
IMA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARTV Artiva Biotherapeutics | $3.82 | -0.26% | 12.68% | $188.83M |
| CNTB Connect Biopharma | $0.63 | -5.56% | -80.06% | $40.51M |
| CNTX Context Therapeutics | $0.17 | 1.32% | -85.59% | $15.49M |
| IFRX InflaRx | $1.02 | -6.42% | -19.05% | $150.32M |
| KLRS Kalaris Therapeutics | $1.35 | -1.46% | -79.79% | $32.14M |
| MGX Metagenomi Therapeutics | $0.61 | -2.85% | -61.88% | $23.21M |
| OVID Ovid Therapeutics | $2.17 | -7.26% | 69.53% | $409.55M |
| STRO Sutro Biopharma | $8.60 | -1.38% | -5.49% | $142.77M |
| STTK Shattuck Labs | $4.47 | -1.76% | 128.06% | $455.24M |
| IMA ImageneBio | $3.98 | 4.46% | -45.70% | $49.58M |